Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

UCB Pharma Limited
208 Bath Road, Slough, Berkshire, SL1 3WE
Telephone: +44 (0)1753 534 655
Medical Information Direct Line: +44 (0)1753 447 690
Medical Information e-mail: Medicalinformationuk@ucb.com
Customer Care direct line: +44 (0) 1773 510123

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 12/04/2012
PIL Vimpat 50 mg, 100 mg, 150 mg & 200 mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/04/2012 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 17/05/2011 and displayed until 12/04/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 05/05/2011 and displayed until 17/05/2011
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to Further Information section
  • Change to warnings or special precautions for use
Updated on 07/12/2010 and displayed until 05/05/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 25/05/2010 and displayed until 07/12/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 18/02/2010 and displayed until 25/05/2010
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 12/09/2008 and displayed until 18/02/2010
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  lacosamide